ask="N/A"
ask_size="N/A"
average_daily_volume="2216"
bid="N/A"
bid_size="N/A"
book_value="0.94"
change="+0.00"
change_from_200_day_moving_average="-0.15"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-2.25"
change_From_52_week_low="0.49"
change_in_percent="+0.00%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.43"
ebitda="-13.10M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="23083000"
high="N/A"
high_52_weeks="5.25"
last_trade_date="1/9/2017"
last_trade_price="3.00"
last_trade_size="N/A"
last_trade_time="10:00am"
low="N/A"
low_52_weeks="2.51"
market_capitalization="107.21M"
moving_average_200_day="3.15"
moving_average_50_day="3.05"
name="Oasmia Pharmaceutical AB - Amer"
notes="N/A"
one_year_target_price="6.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.78%"
percent_change_from_50_day_moving_average="-1.49%"
percent_change_from_52_week_high="-42.86%"
percent_change_from_52_week_low="+19.52%"
previous_close="3.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.19"
price_per_sales="59.79"
revenue="1.79M"
shares_outstanding="35736000"
short_ratio="2.94"
stock_exchange="NCM"
symbol="OASM"
volume="60"
weeks_range_52="2.51 - 5.25"
